Braskem S.A.

NYSE:BAK

Chemicals

Basic Materials
$0.86 -11.76%

-$0.40 today

Market cap
$343.37M
Beta
0.67
P/E (TTM)
-0.7
EPS (TTM)
-$11.45
52W Low $2.32High $5.40

Volume 3.32M

Average 2.97M

BAK Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Braskem S.A.NYSE: BAK

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures growth accelerates

Q1 FY2026 capital expenditures of R$661.39M (cash outflow) rose 1.3% year over year, ahead of the -10.8% change in trailing-twelve-month capital expenditures. Sequentially, it rose 13.5% from the prior quarter. Over 3 fiscal years it compounded at -14.1% a year.

Context

  • Capital expenditures amounted to 4.4% of revenue in FY2025, down 0.4 pp from a year earlier.
  • Capital expenditures grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.3% holds above the trailing-twelve-month pace of -10.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-R$661.39M+13.5% QoQ
Last fiscal yearDec 2025
-R$3.07B-18.4% YoY
LTMMar 2026
-R$3.16B-10.8% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.3%——
1 year-18.4%——
3-year CAGR-14.1%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

BRL · from the cash flow

Latest · FY2025
(3.07B) BRL
Year-over-year change
+18.4%

Capital Expenditures vs competitors

How BAK compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -10.8% is the 7th highest of 10, against a peer median of +24.0%.
  • Capital expenditures amounts to 4.7% of revenue for BAK, versus a peer median of 8.3%.
BAK Competitors
Capital Expenditures for BAK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAKBraskem S.A.LTM Mar 2026R$3.16B BRL-10.8%-14.1%4.7%
SCLStepan CompanyLTM Mar 2026$177.13M USD+356.6%-25.9%7.6%
RYAMRayonier Advanced Materials Inc.LTM Mar 2026$100.49M USD-11.0%-5.7%7.0%
REXREX American Resources CorporationLTM Apr 2026$73.18M USD+37.1%+63.8%11.2%
WLKPWestlake Chemical Partners LPLTM Mar 2026$68.42M USD+24.0%+13.4%5.5%
ECVTEcovyst Inc.LTM Mar 2026$60.28M USD-20.5%+6.1%7.4%
UANCVR Partners, LPLTM Mar 2026$57.98M USD+49.2%+4.4%9.0%
MUXMcEwen Mining Inc.LTM Mar 2026$44.66M USD-15.9%+22.7%18.9%
ASPIASP Isotopes Inc. Common StockLTM Mar 2026$13.43M USD+7.6%+29.2%49.9%
CNLCollective Mining Ltd.LTM Mar 2026$11.23M USD+4716.4%+165.2%—
NAKNorthern Dynasty Minerals Ltd.LTM Mar 2026CA$0 CAD———
Peer median (excluding BAK) —+24.0%+13.4%8.3%

Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income13.98B47M(4.58B)(17.73B)(9.69B)
Depreciation & Amortization4.87B4.73B5.21B4.95B4.58B
Deferred Income Tax00000
Stock-Based Compensation14.39M010M00
Change in Working Capital(12.48B)3.97B(3.96B)557M(1.71B)
Accounts Receivables(2.18B)4.65B72M609M321.56M
Inventory(7.57B)2.14B1.81B(181M)2.88B
Accounts Payables0514M0384M(2.3B)
Other Working Capital(2.73B)(3.34B)(5.84B)(255M)(2.61B)
Other Non-Cash Items8.39B203M1.05B14.66B2.72B
Operating Cash Flow14.79B8.95B(2.27B)2.44B(4.09B)
Capital Expenditures(3.42B)(4.85B)(4.53B)(3.76B)(3.07B)
Acquisitions (Net)0(107M)(78M)203M100M
Purchases of Investments0(64.97M)00(77.45M)
Sales of Investments0000105.88M
Other Investing Activities40.65M72.97M83M73M0
Investing Cash Flow(3.38B)(4.95B)(4.53B)(3.49B)(2.94B)
Debt Repayment(10.97B)1.55B8.28B437M3.2B
Common Stock Issued00000
Common Stock Repurchased00000
Dividends Paid(5.99B)(1.35B)(7M)(6M)0
Other Financing Activities021M596M38M(63.8M)
Financing Cash Flow(16.97B)225M8.87B469M3.13B
Effect of Forex Changes377.53M(444M)(355M)1.38B1.1B
Net Change in Cash(5.18B)3.79B1.72B799M(2.79B)
Free Cash Flow11.37B4.1B(6.8B)(1.33B)(7.16B)

Braskem S.A.

NYSE:BAK

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.